Trevi Therapeutics Inc.

NASDAQ: TRVI
Share price (1/8/25): $4.03
Market cap (1/8/25): $310 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

ended 09/30/23 Q3

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Registration of securities for employees

Shelf registration – amended

Shelf registration

Registration of securities for employees

Ownership Filter

Galletta Christopher

Venrock Healthcare Capital Partners II, L.P.

Rubric Capital Management LP

New Enterprise Associates 16, L.P.

Frazier Life Sciences Public Fund, L.P.

News Filter

Announces Company Updates Ahead of 14th Annual LifeSci Partners Corporate Access Event Held During the J.P. Morgan Healthcare Conference

Announces Pricing of $50 Million Underwritten Offering

Reports Third Quarter 2024 Financial Results and Provides Business Updates

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Scanned paper annual report submission